Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders?
Dryhurst
G
G
Department of Chemistry and Biochemistry, University of Oklahoma, Norman 73019, USA.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000378:metabolism; D000818:Animals; D001927:Brain Diseases / Q000378:metabolism* / Q000473:pathology; D004298:Dopamine / Q000378:metabolism*; D018765:Dopamine Uptake Inhibitors / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008694:Methamphetamine / Q000378:metabolism; D009420:Nervous System / Q000378:metabolism; D019636:Neurodegenerative Diseases / Q000378:metabolism* / Q000473:pathology; D009638:Norepinephrine / Q000378:metabolism*; D011498:Protein Precursors / Q000378:metabolism*; D015427:Reperfusion Injury / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism*
D018765:Dopamine Uptake Inhibitors; D011498:Protein Precursors; D012701:Serotonin; D008694:Methamphetamine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D005978:Glutathione; D004298:Dopamine; D009638:Norepinephrine